Robotic D2 surgery for gastric cancer

Surgical Endoscopy

Volumn 23, Issue 8, 2009, Pages 1919-1921

  Demetetriades, H ^a   Marakis, G N ^a   Ziogas, D ^b   Kanellos, I ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER PREVENTION; CANCER SURGERY; GASTRECTOMY; LAPAROSCOPIC SURGERY; LETTER; PRIORITY JOURNAL; ROBOTICS; STOMACH CANCER; ANASTOMOSIS; CARCINOMA; DISEASE FREE SURVIVAL; FAMILIAL CANCER; GENETICS; HUMAN; INSTRUMENTATION; LAPAROSCOPY; LYMPHADENECTOMY; METHODOLOGY; NOTE; PATHOLOGY; STOMACH TUMOR; SURVIVAL;

CADHERIN; CDH1 PROTEIN, HUMAN;

ANASTOMOSIS, SURGICAL; CADHERINS; CARCINOMA; DISEASE-FREE SURVIVAL; GASTRECTOMY; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; NEOPLASTIC SYNDROMES, HEREDITARY; ROBOTICS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 70349766065     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-009-0496-1     Document Type: Letter

References (33)

1. C Anderson M Hellan K Kernstine J Ellenhorn L Lai V Trisal A Pigazzi 2007 Robotic surgery for gastrointestinal malignancies Int J Med Robot 3 4 297 300 17948920 1:STN:280:DC%2BD1c%2FlsFKhsg%3D%3D
2. PT Ramirez PT Soliman KM Schmeler R dos Reis M Frumovitz 2008 Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer Gynecol Oncol 110 3 Suppl 2 S21 S24 18486966 10.1016/j.ygyno.2008.03.013
3. D Ziogas D Roukos 2008 Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22 5 1405 1406 18320279 10.1007/s00464-008-9796-0
4. R McLeod 2008 Long-term results of laparoscopic-assisted colectomy are comparable to results after open colectomy Ann Surg 248 1 8 9 18580200 10.1097/SLA.0b013e31817c965d
5. Patriti A, Ceccarelli G, Bellochi R, Bartoli A, Spaziani A, Di Zitti L, Casciola L (2008) Robot-assisted laparoscopic total and partial gastric resection with D2 lymph node dissection for adenocarcinoma. Surg Endosc, Sep 24 [Epub ahead of print]
6. M Sasako T Sano S Yamamoto For Japan Clinical Oncology Group, et al. 2008 D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer N Engl J Med 359 5 453 462 18669424 10.1056/NEJMoa0707035 1:CAS:528:DC%2BD1cXpt1Shu7Y%3D
7. T Liakakos DH Roukos 2008 More controversy than ever-challenges and promises towards personalized treatment of gastric cancer Ann Surg Oncol 15 4 956 960 18214617 10.1245/s10434-007-9798-5
8. AM Kappas DH Roukos 2002 Quality of surgery determinant for the outcome of patient with gastric cancer Ann Surg Oncol 9 9 828 830 12417502 10.1007/BF02557517
9. DH Roukos 2004 Early-stage gastric cancer: a highly treatable disease Ann Surg Oncol 11 127 129 14761914 10.1245/ASO.2004.11.903 (Pubitemid 40486786)
10. E Briasoulis M Fatouros DH Roukos 2007 Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14 2691 2695 17653806
11. DH Roukos 2002 Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 9 220 221 11923126 10.1007/BF02573057
12. E Briasoulis T Liakakos L Dova, et al. 2006 Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer Expert Rev Anticancer Ther 6 931 939 16761937 10.1586/14737140.6.6.931 (Pubitemid 44201562)
13. RS Punglia M Morrow EP Winer, et al. 2007 Local therapy and survival in breast cancer N Engl J Med 356 2399 2405 17554121 10.1056/NEJMra065241 1:CAS:528:DC%2BD2sXmt1Wntrg%3D (Pubitemid 46887273)
14. DH Roukos AM Kappas NJ Agnantis 2003 Perspectives and risks of breast-conservation therapy for breast cancer Ann Surg Oncol 10 718 721 12900361 10.1245/ASO.2003.05.925 (Pubitemid 40486870)
15. M Fatouros DH Roukos I Arampatzis A Sotiriadis E Paraskevaidis AM Kappas 2005 Factors increasing local recurrence in breast-conserving surgery Expert Rev Anticancer Ther 5 4 737 745 16111473 10.1586/14737140.5.4.737 (Pubitemid 41223280)
16. DH Roukos 2008 Linking contralateral breast cancer with genetics Radiother Oncol 86 139 141 18237805 10.1016/j.radonc.2008.01.013
17. DC Chung SS Yoon GY Lauwers D Patel 2007 Case records of the Massachusetts General Hospital. Case 22-2007. A woman with a family history of gastric and breast cancer N Engl J Med 357 3 283 291 17634464 10.1056/NEJMcpc079016 1:CAS:528:DC%2BD2sXotVejtrw%3D (Pubitemid 47080394)
18. D Ziogas G Baltogiannis M Fatouros DH Roukos 2008 Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations Ann Surg 247 4 714 715 18362641 10.1097/SLA.0b013e31816a5072
19. DH Roukos S Murray E Briasoulis 2007 Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer Cancer Biol Ther 6 3 308 312 17387266 1:CAS:528: DC%2BD2sXhtVeqsbrN
20. DH Roukos E Briasoulis 2007 Individualized preventive and therapeutic management of hereditary breast ovarian cancer Nat Clin Pract Oncol 4 10 578 590 17898808 10.1038/ncponc0930 1:CAS:528:DC%2BD2sXhtV2isb7N (Pubitemid 47534757)
21. DH Roukos 2007 Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations N Engl J Med 357 15 1555 1556 17933033 10.1056/NEJMc072301 1:CAS:528:DC%2BD2sXhtFKmu77F author reply 1556
22. M Fatouros G Baltoyiannis DH Roukos 2008 The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations Ann Surg Oncol 15 1 21 33 17940826 10.1245/s10434-007-9612-4
23. DH Roukos NJ Agnanti E Paraskevaidis AM Kappas 2002 Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations Ann Surg Oncol 9 10 941 943 12464584
24. NJ Agnantis E Paraskevaidis D Roukos 2004 Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance Ann Surg Oncol 11 12 1030 1034 15545500 10.1245/ASO.2004.09.910 (Pubitemid 40486647)
25. DH Roukos 2008 Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery Expert Rev Mol Diagn 8 5 587 597 18785807 10.1586/14737159.8.5.587
26. DH Roukos E Lykoudis T Liakakos 2008 Genomics and challenges toward personalized breast cancer local control J Clin Oncol 26 26 4360 4361 18779627 10.1200/JCO.2008.18.6197
27. DH Roukos 2008 HER2 and response to paclitaxel in node-positive breast cancer N Engl J Med 358 197 18193530 10.1056/NEJMc073152 1:CAS:528: DC%2BD1cXltFKhsQ%3D%3D author reply 198
28. DH Roukos 2008 Breast-cancer stromal cells with TP53 mutations N Engl J Med 358 15 1636 18411428 1:CAS:528:DC%2BD1cXks1Wjtbc%3D author reply 1636
29. DH Roukos 2009 Radiation therapy for breast cancer N Engl J Med 360 13 1362 1363 19330940 10.1056/NEJMc090162 1:CAS:528:DC%2BD1MXjs1Sgsbo%3D
30. DH Roukos 2009 Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer Ann Surg Oncol 16 4 795 795 19169753 10.1245/s10434-009-0317-8
31. DH Roukos 2009 Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine Ann Surg Oncol 16 3 772 773 18726130 10.1245/s10434-008-0109-6
32. DH Roukos 2009 Genome-wide association studies: how predictable is a person's cancer risk? Expert Rev Anticancer Ther 9 4 389 392 19374592 10.1586/era.09.12
33. DH Roukos 2009 Mea culpa with cancer-targeted therapy: new thinking and new agents design for novel, casual networks-based, personalized biomedicine Expert Rev Mol Diagn 9 3 217 221 19379079 10.1586/erm.09.7